Tg Therapeutics TGTX
NASDAQ TGTX
$55.78 -0.41 (-0.73%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Finished Goods (2023 - 2025)

Updated

Tg Therapeutics' Finished Goods was $21.09 million in Q3 2025, up 164.9% from $7.96 million a year earlier but down 3.5% from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Finished Goods (2023 - 2025) Analysis & Trends

At the end of FY2024, Finished Goods at Tg Therapeutics came in at $13.94 million, up 597.2% from FY2023.

  • In earlier years, Finished Goods was $2 million in FY2023.
  • Quarterly Finished Goods has moved between $52,000 (Q1 2023) and $21.84 million (Q2 2025) over five years.
  • Per Business Quant data, TGTX's Finished Goods in the three quarters before Q3 2025 was $21.84 million (Q2 2025), $10.72 million (Q1 2025) and $13.94 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tg Therapeutics 8.54 Bn 7.93 Bn 199.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 21.09 Mn
Jun 30, 2025 21.84 Mn
Mar 31, 2025 10.72 Mn
Dec 31, 2024 13.94 Mn
Sep 30, 2024 7.96 Mn
Jun 30, 2024 1.62 Mn
Mar 31, 2024 1.90 Mn
Dec 31, 2023 2.00 Mn
Sep 30, 2023 612,000.00
Jun 30, 2023 659,000.00
Mar 31, 2023 52,000.00
API Access

Tg Therapeutics Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=TGTX&period=max&api_key=YOUR_API_KEY